Nanosonics (ASX:NAN) Research & Development : A$32.1 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Nanosonics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Nanosonics's Research & Development for the six months ended in Dec. 2023 was A$16.2 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was A$32.1 Mil.

Nanosonics Research & Development Historical Data

The historical data trend for Nanosonics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosonics Research & Development Chart

Nanosonics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Research & Development

Get a 7-Day Free Trial

11.38

15.56

17.19

22.36

29.51

Nanosonics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Research & Development	Get a 7-Day Free Trial															10.75	11.61	13.64	15.88	16.21

Nanosonics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$32.1 Mil.

Nanosonics (ASX:NAN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nanosonics Research & Development Related Terms

Thank you for viewing the detailed overview of Nanosonics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanosonics (ASX:NAN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanosonics Ltd (ASX:NAN) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

NNCSF:USA OQS:Germany

Address

7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113

Website

https://www.nanosonics.com.au

Nanosonics is a single-product firm and its trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low temperature sonically activated hydrogen peroxide mist that is suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection across patients. Nanosonics' revenue is made up of capital sales of trophon units, ongoing consumables sales, and service revenue. At June 2022, there were 29,850 trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, roughly 44% in the U.S. to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in Asia-Pacific.